Operating Lease, Weighted Average Discount Rate, Percent of Aligos Therapeutics, Inc. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: pure
Description
Weighted average discount rate for operating lease calculated at point in time.
Summary
Aligos Therapeutics, Inc. quarterly Operating Lease, Weighted Average Discount Rate, Percent in pure history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • Aligos Therapeutics, Inc. Operating Lease, Weighted Average Discount Rate, Percent for the quarter ending 31 Dec 2025 was 0.0883, a 0.79% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Weighted Average Discount Rate, Percent, Quarterly (pure)
Operating Lease, Weighted Average Discount Rate, Percent, YoY Quarterly Change (%)

Aligos Therapeutics, Inc. Quarterly Operating Lease, Weighted Average Discount Rate, Percent (pure)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 0.0883 -0.0007 -0.79% 31 Dec 2025 10-K 05 Mar 2026 2025 FY
Q4 2024 0.089 +0.0096 +12% 31 Dec 2024 10-K 05 Mar 2026 2025 FY
Q4 2023 0.0794 -0.011 -12% 31 Dec 2023 10-K 10 Mar 2025 2024 FY
Q4 2022 0.0904 -0.0004 -0.44% 31 Dec 2022 10-K 12 Mar 2024 2023 FY
Q4 2021 0.0908 -0.0027 -2.9% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 0.0941 +0.0006 +0.64% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 0.0938 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 0.0938 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 0.0935 +0.0001 +0.11% 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q3 2020 0.0935 30 Sep 2020 10-Q 25 Nov 2020 2020 Q3
Q4 2019 0.0934 31 Dec 2019 10-K 23 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.